Development of lipid nanoparticles(LNP)- RNA vaccine against <i>Streptococcus pneumoniae</i> gene cluster facilitating the synthesis of the capsular polysaccharide in Egypt.

Design of Lipid nanoparticle (LNP)- RNA vaccine against Haemophilus influenza type b hcsA and hcsB genes facilitating the transport of capsular polysaccharides across the outer m

Pattern of Lipid nanoparticle (LNP)- RNA vaccine against Haemophilus influenza type b hcsA and hcsB genes facilitating the transport of capsular polysaccharides across the outer

Development of lipid nanoparticles mRNA vaccine against viral Influenza infection

Development of lipid nano particles RNA vaccine against hepatitis B surface antigens of hepatitis B virus

Development and characterization of nanostructure lipid carrier for anti-hepatitis-C virus drug

CATIONIC LIPID NANOEMULSION AS A DRUG DELIVERY SYSTEM IN CANCER AND VIRAL IMMUNOTHERAPY

Efficacy of chitosan nanoparticles as adjuvant in development of an inactivated Newcastle Disease Virus(genotype VII) vaccine.

Lipid-Based Nanosystems as Advanced Approach for Drug Delivery

Production and Characterization of Nanostructured -Lipid Carriers as Hormones PGF2αand PMSG